This study is for people with Alzheimer's disease (AD) who experience severe agitation, which means feeling very restless or upset. The goal is to see if a drug called AVP-786 can help. This drug will be compared to a placebo, which is a pill that doesn't have any medicine in it. The study will last for 12 weeks, and participants will take the medicine twice a day. People who want to join need to have a reliable caregiver to help them take the medicine and follow the study rules. A total of 750 participants will join the study in 110 locations worldwide.
Key Points:
- The study will last for 12 weeks, with two doses of medication each day.
- Participants must have Alzheimer's disease and severe agitation.
- A caregiver is needed to help with the study process.